Provider
Fabhalta® (iptacopan) - Commercial
Program effective Date: Jan 01, 2025
Documents & Forms Results
Displaying 601 - 610 of 3111 results
Provider
Atypical Antipsychotics - Commercial
Program effective Date: Jan 01, 2025
Provider
Benign Prostatic Hypertrophy (BPH) - Commercial
Program effective Date: Jan 01, 2025
Provider
Topical Corticosteroids - Commercial
Program effective Date: Jan 01, 2025
Provider
Topical Lidocaine - Medicaid
Program effective Date: Jan 01, 2025
Provider
Topical Lidocaine - Commercial
Program effective Date: Jan 01, 2025
Provider
Topical Doxepin - Medicaid
Program effective Date: Jan 01, 2025
Provider
Topical Doxepin - Commercial
Program effective Date: Jan 01, 2025
Provider
Formulary Exception with Quantity Limit - Standard Guidelines - FlexRx and GenRx
Program effective Date: Jan 01, 2025
Provider
Erectile Dysfunction - Phosphodiesterase Type 5 Inhibitors, Topical Prostaglandin - Commercial
Program effective Date: Jan 01, 2025